Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol via Nebulizer vs DPI in COPD Exacerbation Recovery
NCT02291016Completed
- Sponsor
- University of Tennessee Graduate School of Medicine
- Start
- Feb 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by University of Tennessee Graduate School of Medicine. Primary endpoint: Area Under the Response Curve for FEV1. Started Feb 2015; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02291016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291016.